Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Child Development Disorders, Pervasive: early-phase trial registry
1 of 5 indexed Child Development Disorders, Pervasive trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Child Development Disorders, Pervasive: 5 US clinical trials tracked, 1 recruiting.
Child Development Disorders, Pervasive is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital Medical Center, Cincinnati, running 2 of these trials.
Enrollment posture brief
Registry condition child-development-disorders-pervasive
OPEN 1 | RECR 20% | LATE 0 | EARLY 3 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Child Development Disorders, Pervasive lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Child Development Disorders, Pervasive on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Child Development Disorders, Pervasive is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Child Development Disorders, Pervasive research.
Children's Hospital Medical Center, Cincinnati accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Child Development Disorders, Pervasive enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Child Development Disorders, Pervasive research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
American Federation of Medical Synergetics
NCT03222375
RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
Yale University
NCT00080145
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
Children's Hospital Medical Center, Cincinnati
NCT00147394
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
Children's Hospital Medical Center, Cincinnati
NCT00166595
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Indiana University School of Medicine
NCT00453180
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Child Development Disorders, Pervasive records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Child Development Disorders, Pervasive trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Child Development Disorders, Pervasive page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Child Development Disorders, Pervasive trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospital Medical Center, Cincinnati sponsors the most Child Development Disorders, Pervasive trials on record, review their full trial history before evaluating a specific study. See Children's Hospital Medical Center, Cincinnati's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Child Development Disorders, Pervasive condition card totals 5 registered trials; most-linked intervention Risperidone; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.